Detalles de la búsqueda
1.
Ensuring robustness in the quality of antibiotic susceptibility test discs for four novel antibiotics.
Biomed Chromatogr
; 36(6): e5354, 2022 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-35141944
2.
Activity of cefepime/zidebactam against MDR Escherichia coli isolates harbouring a novel mechanism of resistance based on four-amino-acid inserts in PBP3.
J Antimicrob Chemother
; 75(12): 3563-3567, 2020 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32772098
3.
In Vivo Pharmacokinetic/Pharmacodynamic Targets of Levonadifloxacin against Staphylococcus aureus in a Neutropenic Murine Lung Infection Model.
Antimicrob Agents Chemother
; 63(8)2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-31208999
4.
Comment on: An update on cefepime and its future role in combination with novel ß-lactamase inhibitors for MDR Enterobacterales and Pseudomonas aeruginosa.
J Antimicrob Chemother
; 76(12): 3326-3327, 2021 11 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34179957
5.
Transcending the challenge of evolving resistance mechanisms in Pseudomonas aeruginosa through ß-lactam-enhancer-mechanism-based cefepime/zidebactam.
mBio
; : e0111823, 2023 Oct 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-37889005
6.
New Antimicrobial Agentsââ ââbut No Susceptibility Tests!
Clin Infect Dis
; 63(11): 1530-1531, 2016 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27581762
7.
In vitro activity of cefepime/zidebactam (WCK 5222) against recent Gram-negative isolates collected from high resistance settings of Greek hospitals.
Diagn Microbiol Infect Dis
; 100(3): 115327, 2021 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-33744624
8.
In vitro activity of the quinolone WCK 771 against recent U.S. hospital and community-acquired Staphylococcus aureus pathogens with various resistance types.
Antimicrob Agents Chemother
; 53(2): 811-3, 2009 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-19029326
9.
Levonadifloxacin, a Novel Broad-Spectrum Anti-MRSA Benzoquinolizine Quinolone Agent: Review of Current Evidence.
Drug Des Devel Ther
; 13: 4351-4365, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31920285
10.
Substituted 3-((Z)-2-(4-nitrophenyl)-2-(1H-tetrazol-5-yl) vinyl)-4H-chromen-4-ones as novel anti-MRSA agents: synthesis, SAR, and in-vitro assessment.
Bioorg Med Chem Lett
; 18(16): 4678-81, 2008 Aug 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-18650090
11.
Strategic Approaches to Overcome Resistance against Gram-Negative Pathogens Using ß-Lactamase Inhibitors and ß-Lactam Enhancers: Activity of Three Novel Diazabicyclooctanes WCK 5153, Zidebactam (WCK 5107), and WCK 4234.
J Med Chem
; 61(9): 4067-4086, 2018 05 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-29627985
12.
Synthesis of new series of 1-Aryl-1,4-dihydro-4-oxo-6-methyl pyridazine-3-carboxylic acid as potential antibacterial agents.
Eur J Med Chem
; 40(12): 1325-30, 2005 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-16126308
13.
The anti-methicillin-resistant Staphylococcus aureus quinolone WCK 771 has potent activity against sequentially selected mutants, has a narrow mutant selection window against quinolone-resistant Staphylococcus aureus, and preferentially targets DNA gyrase.
Antimicrob Agents Chemother
; 50(11): 3568-79, 2006 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-16940059
14.
Antistaphylococcal activity of WCK 771, a tricyclic fluoroquinolone, in animal infection models.
Antimicrob Agents Chemother
; 48(12): 4754-61, 2004 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-15561853
15.
In vitro activity of the new quinolone WCK 771 against staphylococci.
Antimicrob Agents Chemother
; 48(9): 3338-42, 2004 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-15328094
Resultados
1 -
15
de 15
1
Próxima >
>>